ResMed Inc. (ASX:RMD)

Market Cap	61.40B
Revenue (ttm)	7.85B
Net Income (ttm)	2.14B
Shares Out	n/a
EPS (ttm)	14.51
PE Ratio	28.74
Forward PE	25.22
Dividend	0.50 (1.19%)
Ex-Dividend Date	Aug 13, 2025

Volume	1,249,279
Average Volume	1,002,367
Open	42.04
Previous Close	41.47
Day's Range	42.03 - 42.59
52-Week Range	32.04 - 45.25
Beta	0.77
RSI	46.24
Earnings Date	Oct 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD